WIPI1抗体;WIPI1 Antibody—艾普蒂

+ +

•  

   

     Western blot analysis of WIPI1 expression in A375 cell lysate.    

  
  

•  

   

     All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.    

  
  

•  

   

     All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.    

  
  

The WIPI1 (WD repeat domain, phosphoinositide interacting 1) antibody is a tool used to study the WIPI1 protein, a member of the WD40 repeat protein family involved in autophagy, a critical cellular degradation process. WIPI1 functions as a phosphatidylinositol 3-phosphate (PI3P)-binding protein that localizes to autophagosomal membranes, playing a key role in autophagosome formation by recruiting other autophagy-related proteins like ATG5-ATG12 and LC3. It acts as a scaffold, linking phosphoinositide signaling to autophagic machinery, particularly during the early stages of autophagosome biogenesis.

Antibodies targeting WIPI1 are widely used in research to detect its expression, localization, and dynamics via techniques such as Western blotting, immunofluorescence, and immunohistochemistry. These studies help elucidate WIPI1's role in cellular homeostasis, stress responses, and diseases like cancer, neurodegenerative disorders, and lysosomal storage diseases, where autophagy dysregulation is implicated. WIPI1 expression is also regulated by nutrient availability and mTOR signaling, making its antibody valuable for investigating metabolic pathways.

Mutations or altered WIPI1 levels correlate with pathological conditions, underscoring its potential as a therapeutic target or biomarker. Researchers rely on WIPI1 antibodies to explore its interactions, post-translational modifications, and contributions to disease mechanisms, advancing understanding of autophagy-related pathologies and treatments.